AMS
American Shared Hospital Services
Medical - Care Facilities
Market Cap$13M
5Y Perf.-31.4%
Compare Stocks
4 / 10Try these comparisons:
Stock Comparison
AMS vs NNOX vs GEHC vs NVCR
Revenue, margins, valuation, and 5-year total return — side by side.
NNOX
Nano-X Imaging Ltd.
Medical - Devices
Market Cap$115M
5Y Perf.-76.2%
GEHC
GE HealthCare Technologies Inc.
Medical - Healthcare Information Services
Market Cap$27.90B
5Y Perf.+5.1%
NVCR
NovoCure Limited
Medical - Instruments & Supplies
Market Cap$1.92B
5Y Perf.-77.1%
AMS vs NNOX vs GEHC vs NVCR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | AMS | NNOX | GEHC | NVCR |
|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Devices | Medical - Healthcare Information Services | Medical - Instruments & Supplies |
| Market Cap | $13M | $115M | $27.90B | $1.92B |
| Revenue (TTM) | $29M | $12M | $19.95B | $674M |
| Net Income (TTM) | $-2M | $-56M | $1.50B | $-173M |
| Gross Margin | 25.0% | -98.8% | 42.5% | 75.2% |
| Operating Margin | -12.3% | -469.7% | 12.5% | -27.2% |
| Forward P/E | 6.1x | — | 12.4x | — |
| Total Debt | $23M | $7M | $10.00B | $290M |
| Cash & Equiv. | $11M | $39M | $4.51B | $103M |
AMS vs NNOX vs GEHC vs NVCR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
AMS
NNOX
GEHC
NVCR
| Stock | Dec 22 | May 26 | Return |
|---|---|---|---|
| American Shared Hos… (AMS) | 100 | 68.6 | -31.4% |
| Nano-X Imaging Ltd. (NNOX) | 100 | 23.8 | -76.2% |
| GE HealthCare Techn… (GEHC) | 100 | 105.1 | +5.1% |
| NovoCure Limited (NVCR) | 100 | 22.9 | -77.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AMS vs NNOX vs GEHC vs NVCR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: GEHC leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. American Shared Hospital Services is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. NVCR also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
AMS
American Shared Hospital Services
The Growth Play
AMS is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 32.9%, EPS growth 245.9%, 3Y rev CAGR 17.1%
- PEG 0.93 vs GEHC's 19.78
- 32.9% revenue growth vs GEHC's 4.8%
- Better valuation composite
Best for: growth exposure and valuation efficiency
NNOX
Nano-X Imaging Ltd.
The Defensive Pick
NNOX is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.86, Low D/E 3.9%, current ratio 5.63x
- Beta 1.86, current ratio 5.63x
Best for: sleep-well-at-night and defensive
GEHC
GE HealthCare Technologies Inc.
The Income Pick
GEHC carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 3 yrs, beta 1.37, yield 0.2%
- 2.9% 10Y total return vs NVCR's 30.3%
- 7.5% margin vs NNOX's -452.8%
- Beta 1.37 vs NVCR's 2.20
Best for: income & stability and long-term compounding
NVCR
NovoCure Limited
The Momentum Pick
NVCR is the clearest fit if your priority is momentum.
- +1.1% vs NNOX's -64.4%
Best for: momentum
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | AMS | 32.9% revenue growth vs GEHC's 4.8% |
| Value | AMS | Better valuation composite |
| Quality / Margins | GEHC | 7.5% margin vs NNOX's -452.8% |
| Stability / Safety | GEHC | Beta 1.37 vs NVCR's 2.20 |
| Dividends | GEHC | 0.2% yield; 3-year raise streak; the other 3 pay no meaningful dividend |
| Momentum (1Y) | NVCR | +1.1% vs NNOX's -64.4% |
| Efficiency (ROA) | GEHC | 4.1% ROA vs NNOX's -31.6%, ROIC 13.3% vs -27.9% |
AMS vs NNOX vs GEHC vs NVCR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
Segment breakdown not available.
FY 2025
Segment breakdown not available.
AMS vs NNOX vs GEHC vs NVCR — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLGEHCLAGGINGNVCR
Who Leads Where
GEHC leads in 3 of 6 categories
AMS leads 1 • NNOX leads 0 • NVCR leads 0 • 2 tied
Explore the data ↓NVCRNovoCure Limited
0leads
NNOXNano-X Imaging Ltd.
0leads
AMSAmerican Shared Hospi…
1leads
GEHCGE HealthCare Technol…
3leads
6 Total Categories
CATEGORYLEADERvs AMSvs NNOXMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
GEHC3/6
Valuation MetricsMultiples, price ratios, and targets
AMS4/5
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
GEHC5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
Tied
—
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
GEHC1/1
Income & Cash Flow (Last 12 Months)
GEHC leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GEHC is the larger business by revenue, generating $20.0B annually — 1622.0x NNOX's $12M. GEHC is the more profitable business, keeping 7.5% of every revenue dollar as net income compared to NNOX's -4.5%. On growth, NNOX holds the edge at +13.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | AMSAmerican Shared H… | NNOXNano-X Imaging Lt… | GEHCGE HealthCare Tec… | NVCRNovoCure Limited |
|---|---|---|---|---|
| RevenueTrailing 12 months | $29M | $12M | $20.0B | $674M |
| EBITDAEarnings before interest/tax | $2M | -$46M | $3.3B | -$165M |
| Net IncomeAfter-tax profit | -$2M | -$56M | $1.5B | -$173M |
| Free Cash FlowCash after capex | -$10M | -$47M | $1.5B | -$48M |
| Gross MarginGross profit ÷ Revenue | +25.0% | -98.8% | +42.5% | +75.2% |
| Operating MarginEBIT ÷ Revenue | -12.3% | -4.7% | +12.5% | -27.2% |
| Net MarginNet income ÷ Revenue | -7.6% | -4.5% | +7.5% | -25.7% |
| FCF MarginFCF ÷ Revenue | -34.7% | -3.8% | +7.6% | -7.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.5% | +13.7% | +7.4% | +12.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -56.7% | +8.7% | -30.9% | -100.0% |
GEHC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
AMS leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
At 6.1x trailing earnings, AMS trades at a 55% valuation discount to GEHC's 13.5x P/E. Adjusting for growth (PEG ratio), AMS offers better value at 0.93x vs GEHC's 19.78x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | AMSAmerican Shared H… | NNOXNano-X Imaging Lt… | GEHCGE HealthCare Tec… | NVCRNovoCure Limited |
|---|---|---|---|---|
| Market CapShares × price | $13M | $115M | $27.9B | $1.9B |
| Enterprise ValueMkt cap + debt − cash | $25M | $83M | $33.4B | $2.1B |
| Trailing P/EPrice ÷ TTM EPS | 6.09x | -1.93x | 13.48x | -13.80x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 12.40x | — |
| PEG RatioP/E ÷ EPS growth rate | 0.93x | — | 19.78x | — |
| EV / EBITDAEnterprise value multiple | 7.51x | — | 10.00x | — |
| Price / SalesMarket cap ÷ Revenue | 0.46x | 10.20x | 1.35x | 2.92x |
| Price / BookPrice ÷ Book value/share | 0.45x | 0.55x | 2.66x | 5.51x |
| Price / FCFMarket cap ÷ FCF | — | — | 18.53x | — |
AMS leads this category, winning 4 of 5 comparable metrics.
Profitability & Efficiency
GEHC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GEHC delivers a 14.4% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-51 for NVCR. NNOX carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to GEHC's 0.94x. On the Piotroski fundamental quality scale (0–9), AMS scores 5/9 vs GEHC's 4/9, reflecting solid financial health.
| Metric | AMSAmerican Shared H… | NNOXNano-X Imaging Lt… | GEHCGE HealthCare Tec… | NVCRNovoCure Limited |
|---|---|---|---|---|
| ROE (TTM)Return on equity | -7.9% | -35.5% | +14.4% | -50.8% |
| ROA (TTM)Return on assets | -3.8% | -31.6% | +4.1% | -16.5% |
| ROICReturn on invested capital | -5.8% | -27.9% | +13.3% | -16.4% |
| ROCEReturn on capital employed | -6.4% | -28.4% | +10.8% | -28.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.77x | 0.04x | 0.94x | 0.85x |
| Net DebtTotal debt minus cash | $12M | -$32M | $5.5B | $187M |
| Cash & Equiv.Liquid assets | $11M | $39M | $4.5B | $103M |
| Total DebtShort + long-term debt | $23M | $7M | $10.0B | $290M |
| Interest CoverageEBIT ÷ Interest expense | -1.35x | -379.29x | 5.35x | -96.80x |
GEHC leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
Evenly matched — GEHC and NVCR each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GEHC five years ago would be worth $10,293 today (with dividends reinvested), compared to $605 for NNOX. Over the past 12 months, NVCR leads with a +1.1% total return vs NNOX's -64.4%. The 3-year compound annual growth rate (CAGR) favors GEHC at -8.0% vs NNOX's -52.4% — a key indicator of consistent wealth creation.
| Metric | AMSAmerican Shared H… | NNOXNano-X Imaging Lt… | GEHCGE HealthCare Tec… | NVCRNovoCure Limited |
|---|---|---|---|---|
| YTD ReturnYear-to-date | -4.3% | -37.8% | -25.9% | +28.3% |
| 1-Year ReturnPast 12 months | -27.4% | -64.4% | -10.7% | +1.1% |
| 3-Year ReturnCumulative with dividends | -28.0% | -89.2% | -22.2% | -75.7% |
| 5-Year ReturnCumulative with dividends | -41.1% | -93.9% | +2.9% | -91.3% |
| 10-Year ReturnCumulative with dividends | -4.7% | -96.1% | +2.9% | +30.3% |
| CAGR (3Y)Annualised 3-year return | -10.4% | -52.4% | -8.0% | -37.6% |
Evenly matched — GEHC and NVCR each lead in 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — AMS and NVCR each lead in 1 of 2 comparable metrics.
Risk & Volatility
AMS is the less volatile stock with a -0.02 beta — it tends to amplify market swings less than NVCR's 2.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVCR currently trades 83.9% from its 52-week high vs NNOX's 30.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | AMSAmerican Shared H… | NNOXNano-X Imaging Lt… | GEHCGE HealthCare Tec… | NVCRNovoCure Limited |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.02x | 1.86x | 1.37x | 2.20x |
| 52-Week HighHighest price in past year | $3.11 | $5.86 | $89.77 | $20.06 |
| 52-Week LowLowest price in past year | $1.25 | $1.66 | $58.75 | $9.82 |
| % of 52W HighCurrent price vs 52-week peak | +64.6% | +30.0% | +68.3% | +83.9% |
| RSI (14)Momentum oscillator 0–100 | 63.8 | 38.5 | 32.1 | 69.8 |
| Avg Volume (50D)Average daily shares traded | 138K | 1.4M | 4.3M | 1.5M |
Evenly matched — AMS and NVCR each lead in 1 of 2 comparable metrics.
Analyst Outlook
GEHC leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: NNOX as "Buy", GEHC as "Buy", NVCR as "Buy". Consensus price targets imply 922.7% upside for NNOX (target: $18) vs 36.9% for GEHC (target: $84). GEHC is the only dividend payer here at 0.23% yield — a key consideration for income-focused portfolios.
| Metric | AMSAmerican Shared H… | NNOXNano-X Imaging Lt… | GEHCGE HealthCare Tec… | NVCRNovoCure Limited |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $18.00 | $84.00 | $33.50 |
| # AnalystsCovering analysts | — | 5 | 18 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.2% | — |
| Dividend StreakConsecutive years of raises | 0 | — | 3 | — |
| Dividend / ShareAnnual DPS | — | — | $0.14 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.7% | 0.0% |
GEHC leads this category, winning 1 of 1 comparable metric.
Key Takeaway
GEHC leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AMS leads in 1 (Valuation Metrics). 2 tied.
Best OverallGE HealthCare Technologies … (GEHC)Leads 3 of 6 categories
Loading custom metrics...
AMS vs NNOX vs GEHC vs NVCR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AMS or NNOX or GEHC or NVCR a better buy right now?
For growth investors, American Shared Hospital Services (AMS) is the stronger pick with 32.
9% revenue growth year-over-year, versus 4. 8% for GE HealthCare Technologies Inc. (GEHC). American Shared Hospital Services (AMS) offers the better valuation at 6. 1x trailing P/E, making it the more compelling value choice. Analysts rate Nano-X Imaging Ltd. (NNOX) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AMS or NNOX or GEHC or NVCR?
On trailing P/E, American Shared Hospital Services (AMS) is the cheapest at 6.
1x versus GE HealthCare Technologies Inc. at 13. 5x.
03Which is the better long-term investment — AMS or NNOX or GEHC or NVCR?
Over the past 5 years, GE HealthCare Technologies Inc.
(GEHC) delivered a total return of +2. 9%, compared to -93. 9% for Nano-X Imaging Ltd. (NNOX). Over 10 years, the gap is even starker: NVCR returned +30. 3% versus NNOX's -96. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AMS or NNOX or GEHC or NVCR?
By beta (market sensitivity over 5 years), American Shared Hospital Services (AMS) is the lower-risk stock at -0.
02β versus NovoCure Limited's 2. 20β — meaning NVCR is approximately -14141% more volatile than AMS relative to the S&P 500. On balance sheet safety, Nano-X Imaging Ltd. (NNOX) carries a lower debt/equity ratio of 4% versus 94% for GE HealthCare Technologies Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AMS or NNOX or GEHC or NVCR?
By revenue growth (latest reported year), American Shared Hospital Services (AMS) is pulling ahead at 32.
9% versus 4. 8% for GE HealthCare Technologies Inc. (GEHC). On earnings-per-share growth, the picture is similar: American Shared Hospital Services grew EPS 245. 9% year-over-year, compared to 4. 8% for GE HealthCare Technologies Inc.. Over a 3-year CAGR, NNOX leads at 105. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AMS or NNOX or GEHC or NVCR?
GE HealthCare Technologies Inc.
(GEHC) is the more profitable company, earning 10. 1% net margin versus -474. 3% for Nano-X Imaging Ltd. — meaning it keeps 10. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEHC leads at 13. 4% versus -502. 9% for NNOX. At the gross margin level — before operating expenses — NVCR leads at 74. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AMS or NNOX or GEHC or NVCR more undervalued right now?
Analyst consensus price targets imply the most upside for NNOX: 922.
7% to $18. 00.
08Which pays a better dividend — AMS or NNOX or GEHC or NVCR?
In this comparison, GEHC (0.
2% yield) pays a dividend. AMS, NNOX, NVCR do not pay a meaningful dividend and should not be held primarily for income.
09Is AMS or NNOX or GEHC or NVCR better for a retirement portfolio?
For long-horizon retirement investors, American Shared Hospital Services (AMS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
02)). NovoCure Limited (NVCR) carries a higher beta of 2. 20 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AMS: -4. 7%, NVCR: +30. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AMS and NNOX and GEHC and NVCR?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AMS is a small-cap high-growth stock; NNOX is a small-cap quality compounder stock; GEHC is a mid-cap deep-value stock; NVCR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(AMS: 2.5% · NNOX: 13.7%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.